RealTimeTouch.com RealTimeTouch.com Patent US9639150 RealTimeTouch.com message RealTimeTouch.com RealTimeTouch.com



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




RealTimeTouch.com RealTimeTouch.com Patent US9639150 RealTimeTouch.com message RealTimeTouch.com RealTimeTouch.com
  

Ferring B v patents

Recent patent applications related to Ferring B v. Ferring B v is listed as an Agent/Assignee. Note: Ferring B v may have other listings under different names/spellings. We're not affiliated with Ferring B v, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "F" | Ferring B v-related inventors




Date Ferring B v patents (updated weekly) - BOOKMARK this page
05/11/17Stabilized desmopressin
04/27/17Misoprostol composition
04/27/17Pharmaceutical formulations
04/20/17Pharmaceutical composition
04/20/17Pharmaceutical composition
02/23/17Liquid formulations containing picosulfate and magnesium citrate
02/09/17Method of treating prostate cancer with gnrh antagonist
12/29/16Positive modulator of bone morphogenic protein-2
09/29/16Method and system for diagnosing uterine contraction levels using image analysis
09/29/16Monolithic intravaginal rings comprising progesterone and methods of making and uses thereof
09/01/16Methods of treating infertility
08/11/16Microparticles comprising gnrh made by pgss
07/28/16Method for controlled ovarian stimulation
06/23/16Pharmaceutical formulations
06/23/16Oxytocin receptor antagonist therapy in the luteal phase for implantation and pregnancy in women undergoing assisted reproductive technologies
05/26/16Bacteriophage therapy
05/26/16Process for the manufacture of degarelix and its intermediates
05/19/16Extended release nicotinamide formulation
05/05/16V1a receptor agonists
10/29/15Composition for immediate and extended release
10/29/15Vasopressin-2 receptor agonists
10/22/15Diclofenac formulations
10/15/15Tranexamic acid formulations
10/15/15Tranexamic acid formulations
09/24/15Stabilization of fsh
09/03/15Pharmaceutical composition
09/03/15Cell-free dna as a therapeutic target for female infertility and diagnostic marker
08/27/15Misoprostol formulation
07/30/15High drug load mesalazine sachet
06/25/15Misoprostol composition
06/18/15Hydrophilic polyurethane compositions
06/04/15Fast dissolving pharmaceutical composition
06/04/15Pharmaceutical formulations
05/21/15Manufacture of degarelix
05/07/15V1a receptor agonists
04/23/15Testosterone formulations
02/12/15Fast dissolving pharmaceutical composition
01/15/15Tranexamic acid formulations
11/06/14Granules for pharmaceutical preparations, methods and their production
09/25/14Composition for the treatment of fistula
09/11/14Process for production of recombinant human growth hormone
09/04/14Pharmaceutical preparation comprising recombinant hcg
08/28/14Device and delivering a dose of medicament comprising activated carbon particles
08/07/14Applicator system for applying a viscous liquid to the human skin
07/24/14Bioresorbable microparticles
07/10/14Method for the preparation of a pharmaceutical composition comprising 5-aminosalicylic acid for use in treatment of ulcerative colitis and crohn's disease
07/10/14Treatment of endometriosis
04/24/14Methods comprising desmopressin
04/17/14Water-swellable polymers
03/27/14Pharmaceutical preparation
11/21/13Fast dissolving pharmaceutical composition
11/07/13Testosterone formulations
10/24/13Process for the manufacture of degarelix and its intermediates
10/24/13Process for the manufacture of degarelix and its intermediates
08/15/13Stabilization of fsh
08/15/13Pharmaceutical composition
08/01/13Method for the preparation of a pharmaceutical composition comprising 5-aminosalicylic acid for use in treatment of ulcerative colitis and crohn's disease
08/01/13Intravaginal administration of misoprostol
07/04/13Process for production of recombinant human growth hormone
05/16/13Fast dissolving pharmaceutical composition
05/16/13Fast dissolving pharmaceutical composition
04/18/13Tranexamic acid formulations
01/24/13Granules for pharmaceutical preparations, methods and their production
01/24/13Pharmaceutical preparation comprising recombinant hcg
01/17/13Tranexamic acid formulations
Patent Packs
01/10/13Tranexamic acid formulations
12/27/12Coating method
12/27/12Polyurethane elastomers
11/29/12Water-swellable polymers
11/22/12Methods and handling outgoing electronic messages in a user terminal
09/13/12Peptidic glp-2 agonists
08/02/12Peptidic vasopressin receptor agonists
03/22/12Pharmaceutical formulatons
01/19/12Unitary combinations of fsh and hcg
09/22/11Tranexamic acid formulations
08/11/11Peptidic pth receptor agonists
03/03/11The use of gnrh antagonist peptide in the treatement of sex hormone-dependent diseases
02/24/11Oxytocin analogues
02/10/11Pharmaceutical composition as solid dosage form and manufacturing thereof
12/09/10Use of v2 receptor antagonists in combination with vaso pressinergic agnosts
Patent Packs
10/14/10Use of novel compounds for ibd treatment
12/24/09Pharmaceutical formulations
12/10/09Use of peptidic vasopressin receptor agonists
11/05/09Novel compounds
02/26/09Peptidic vasopressin receptor agonists







ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Ferring B v in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Ferring B v with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';